Shares of Canopy Growth Corp (TSE:WEED – Get Free Report) hit a new 52-week high on Tuesday . The company traded as high as C$16.75 and last traded at C$15.57, with a volume of 5909081 shares traded. The stock had previously closed at C$11.36.
Wall Street Analyst Weigh In
A number of analysts recently commented on the company. Bank of America dropped their price target on Canopy Growth from C$7.00 to C$4.00 in a research note on Wednesday, February 14th. Jefferies Financial Group dropped their target price on shares of Canopy Growth from C$7.28 to C$4.90 and set a “hold” rating for the company in a research report on Tuesday, February 27th. Finally, Sanford C. Bernstein increased their price target on shares of Canopy Growth from C$1.49 to C$6.70 in a research note on Tuesday, January 30th.
Check Out Our Latest Stock Analysis on Canopy Growth
Canopy Growth Stock Performance
About Canopy Growth
Canopy Growth Corporation, together with its subsidiaries, engages in growing, possession, and sale of medical cannabis in Canada. Its products include dried flowers, oils and concentrates, softgel capsules, and hemps. The company offers its products under the Tweed, Black Label, Spectrum Cannabis, DNA Genetics, Leafs By Snoop, CraftGrow, and Foria brand names.
Read More
- Five stocks we like better than Canopy Growth
- Retail Stocks Investing, Explained
- NXP Semiconductors Will Set a New High Soon: $300 in Sight
- The Significance of Brokerage Rankings in Stock Selection
- Hilton Demonstrates Asset Light is Right for Investors
- Are Penny Stocks a Good Fit for Your Portfolio?
- Boston Scientific Bucks the Medtech Slow Down and Raises Outlook
Receive News & Ratings for Canopy Growth Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Canopy Growth and related companies with MarketBeat.com's FREE daily email newsletter.